Ana González Moreno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana González Moreno has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ana Rosado Ingelmo
Allergy Unit Hospital Universitario Fundación Alcorcón Madrid Spain
3 shared publicationsMarianela Brandoni Petroni
Allergy Unit Hospital Universitario Fundación Alcorcón Madrid Spain
3 shared publications- Ana Rosado
Unidad de Alergia, Hospital Universitario Fundación Alcorcón, Madrid, Spain
2 shared publications Elia Pérez-Fernández
University Hospital Fundación Alcorcón
2 shared publications- Miguel Angel Tejedor-Alonso
Allergy Unit Hospital Universitario Fundación Alcorcón Madrid Spain
2 shared publications - Miguel Tejedor-Alonso A
Hospital Universitario Fundación Alcorcón
2 shared publications
Latest Publications
- 10 March 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (3) , e70057
Natural history of cross intolerance to non‐steroidal anti‐inflammatory drugs in the pediatric population
- 10 March 2025
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 36 (3) , e70057
Natural history of cross intolerance to non‐steroidal anti‐inflammatory drugs in the pediatric population
- Open Access
- 25 July 2024
- Published by Wiley
Natural history of cross intolerance to non-steroidal anti-inflammatory drugs in the paediatric population
Background : Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the main causes of hypersensitivity to drugs in the paediatric population. Studies about the natural history of cross-intolerance reactions to NSAIDs are scarce. The aim of this study was to assess cross intolerance to NSAIDs over time in the paediatric population. Methods : Retrospective study in patients under 18 years old diagnosed with cross intolerance to NSAIDs by oral challenge test between 1999 and 2019. These patients were prospectively re-assessed in 2021-2022 by challenge with acetylsalicylic acid (ASA). Patient characteristics and potential factors that might have helped them develop tolerance to NSAIDs were analysed. Results : Between 1999 and 2019, 46 patients were diagnosed with cross intolerance to NSAIDs; of these, 19 were re-assessed at a second visit after a mean of 116 months from initial diagnosis. The NSAID most involved in reactions was ibuprofen. At Visit 2, it was observed that 15 (78.9%) patients tolerated ASA and other NSAIDs. Patients with atopy and who initially presented with asthma were more likely to maintain their diagnosis of cross intolerance to NSAIDs ( p =0.001 and p =0.035, respectively). On the contrary, most patients with initial angioedema developed tolerance over time ( p =0.035). Conclusion : Patients with cross intolerance to NSAIDs may develop tolerance to them over time. This tolerance might be determined both by the presence of atopy and the initial history of the patient.
- 25 July 2024
- Published by Wiley
Open AccessNatural history of cross intolerance to non-steroidal anti-inflammatory drugs in the paediatric population
Background : Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the main causes of hypersensitivity to drugs in the paediatric population. Studies about the natural history of cross-intolerance reactions to NSAIDs are scarce. The aim of this study was to assess cross intolerance to NSAIDs over time in the paediatric population. Methods : Retrospective study in patients under 18 years old diagnosed with cross intolerance to NSAIDs by oral challenge test between 1999 and 2019. These patients were prospectively re-assessed in 2021-2022 by challenge with acetylsalicylic acid (ASA). Patient characteristics and potential factors that might have helped them develop tolerance to NSAIDs were analysed. Results : Between 1999 and 2019, 46 patients were diagnosed with cross intolerance to NSAIDs; of these, 19 were re-assessed at a second visit after a mean of 116 months from initial diagnosis. The NSAID most involved in reactions was ibuprofen. At Visit 2, it was observed that 15 (78.9%) patients tolerated ASA and other NSAIDs. Patients with atopy and who initially presented with asthma were more likely to maintain their diagnosis of cross intolerance to NSAIDs ( p =0.001 and p =0.035, respectively). On the contrary, most patients with initial angioedema developed tolerance over time ( p =0.035). Conclusion : Patients with cross intolerance to NSAIDs may develop tolerance to them over time. This tolerance might be determined both by the presence of atopy and the initial history of the patient.
- Open Access
- 16 July 2024
- Published by Wiley
Natural history of cross intolerance to non-steroidal anti-inflammatory drugs in the pediatric population
- 16 July 2024
- Published by Wiley
Open AccessNatural history of cross intolerance to non-steroidal anti-inflammatory drugs in the pediatric population
- 5 September 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (12) , 1314-1317
Integration of beta‐lactam allergy evaluation in a Spanish antibiotic stewardship programme
- 5 September 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (12) , 1314-1317
Integration of beta‐lactam allergy evaluation in a Spanish antibiotic stewardship programme
- 30 July 2022
- Published by Springer Nature in Current Treatment Options in Allergy
- Vol. 9 (3) , 219-233
De-labeling Beta-lactam in Adult Population
- 30 July 2022
- Published by Springer Nature in Current Treatment Options in Allergy
- Vol. 9 (3) , 219-233
De-labeling Beta-lactam in Adult Population